Literature DB >> 16424430

Addressing resource allocation issues in recommendations from clinical practice guideline panels: suggestions from an American College of Chest Physicians task force.

Gordon Guyatt1, Michael Baumann, Stephen Pauker, Jonathan Halperin, Janet Maurer, Douglas K Owens, Anna N A Tosteson, Brian Carlin, David Gutterman, Martin Prins, Sandra Zelman Lewis, Holger Schünemann.   

Abstract

Most panels that develop clinical practice guidelines are poorly equipped to address resource allocation or cost issues associated with management options. This risks neglect, arbitrariness, lack of transparency, and methodological flaws in consideration of resource allocation. We provide recommendations for guideline panels to promote greater transparency and rigor. We suggest focusing on resource allocation issues for only a limited number of recommendations and provide criteria for selecting those in which economic considerations are likely to influence the direction or strength of the recommendation. Panels should involve a health economist to assist with the systematic review and critical interpretation of relevant economic analyses. They should carefully define the intended audience and may consider issuing alternative recommendations when available resources vary widely across target clinical settings. Targeting a limited number of recommendations for the consideration of resource allocation issues, and ensuring methodologically high-quality review, will best serve guideline panels, and the health-care providers and patients they hope to assist.

Entities:  

Mesh:

Year:  2006        PMID: 16424430     DOI: 10.1378/chest.129.1.182

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Measuring preferences for cost-utility analysis: how choice of method may influence decision-making.

Authors:  Christine M McDonough; Anna N A Tosteson
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Susan L Norris; Sam Schulman; Jack Hirsh; Mark H Eckman; Elie A Akl; Mark Crowther; Per Olav Vandvik; John W Eikelboom; Marian S McDonagh; Sandra Zelman Lewis; David D Gutterman; Deborah J Cook; Holger J Schünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  International guidelines: Adoption or adaptation by the Saudi Heart Association?

Authors:  Mahmoud Elbarbary
Journal:  J Saudi Heart Assoc       Date:  2009-08-05

Review 4.  Incorporating considerations of resources use into grading recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Roman Jaeschke; Mark Helfand; Alessandro Liberati; Gunn E Vist; Holger J Schünemann
Journal:  BMJ       Date:  2008-05-24

Review 5.  Clinical practice guidelines to inform evidence-based clinical practice.

Authors:  J Stuart Wolf; Heddy Hubbard; Martha M Faraday; John B Forrest
Journal:  World J Urol       Date:  2011-02-18       Impact factor: 4.226

6.  A new method for examining the cost savings of reducing COPD exacerbations.

Authors:  Douglas W Mapel; Michael Schum; Eva Lydick; Jeno P Marton
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

7.  Cost-effective osteoporosis treatment thresholds: the United States perspective.

Authors:  A N A Tosteson; L J Melton; B Dawson-Hughes; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

8.  Decision Analysis and Cost-effectiveness Analysis.

Authors:  Hilary F Ryder; Christine McDonough; Anna N A Tosteson; Jon D Lurie
Journal:  Semin Spine Surg       Date:  2009-12

9.  Cost-Effectiveness Evaluation of EHR: Simulation of an Abdominal Aortic Aneurysm in the Emergency Department.

Authors:  Ofir Ben-Assuli; Amitai Ziv; Doron Sagi; Avinoah Ironi; Moshe Leshno
Journal:  J Med Syst       Date:  2016-04-25       Impact factor: 4.460

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.